Latest Articles

Publication Date
11-inch Apple iPad Pro (M5) deal: $899.99 at Amazon - Mashable

11-inch Apple iPad Pro (M5) deal: $899.99 at Amazon Mashable

Published: Feb. 11, 2026, 8:31 p.m.
Dietary Caloric Restriction Suppresses Endometriosis by Inhibiting STAT3/ERK Pathways.

Endometriosis is a chronic, estrogen-dependent inflammatory condition that affects approximately 10% of reproductive-age women and is frequently associated with infertility and pelvic pain. Unlike many estrogen-dependent disorders, epidemiologic studies have …

Published: Feb. 11, 2026, midnight
Diagnosis and Therapy of Endometriosis. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/045, April 2025).

Objective The objective of this revised official guideline, published by the German Society for Gynecology and Obstetrics (DGGG) and coordinated in the joint guidelines program of the DGGG, the Austrian …

Published: Feb. 11, 2026, midnight
Barriers and Facilitators Affecting the Care of Patients with Endometriosis: A Scoping Review.

Endometriosis affects around 10-15% of women of reproductive age worldwide. Despite its prevalence and the considerable pain and psychological stress associated with the disease, the care of those affected is …

Published: Feb. 11, 2026, midnight
Obstructed Hemivagina with Ipsilateral Renal Anomaly: Radiological Diagnosis, Outcome of Surgical Management and Literature Review.

Background and Clinical Significance: Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome is a rare Müllerian duct anomaly that is frequently misdiagnosed as primary dysmenorrhea, resulting in delayed intervention and …

Published: Feb. 11, 2026, midnight
Can this new app reduce endometriosis diagnosis waiting times? - Stylist

Can this new app reduce endometriosis diagnosis waiting times? Stylist

Published: Feb. 10, 2026, 3:45 p.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IBTimes India

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IBTimes India

Published: Feb. 10, 2026, 11:57 a.m.
AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment - scanx.trade

AstraZeneca Pharma India Receives CDSCO Approval for Imfinzi Cancer Treatment scanx.trade

Published: Feb. 10, 2026, 10:22 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment - IANS LIVE

AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment IANS LIVE

Published: Feb. 10, 2026, 10:07 a.m.
AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug - Equitypandit

AstraZeneca Shares Surge 3% on CDSCO Approval for Cancer Drug Equitypandit

Published: Feb. 10, 2026, 9:36 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!